Skip to main content

Advertisement

Fig. 6 | BMC Neurology

Fig. 6

From: Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Fig. 6

The patient’s treatment satisfaction with THC:CBD, as assessed by Treatment Satisfaction Questionnaire for Medication (TSQM-9). The score was evaluated separately in nine questions, which are as follows. Question 1 (a) – ability of THC:CBD to prevent or treat spasticity: “How satisfied or dissatisfied are you with the ability of THC:CBD to prevent or treat your spasticity?”; Question 2 (b) – the way THC:CBD relieves spasticity: “How satisfied or dissatisfied are you with the way THC:CBD relieves your symptoms?”; Question 3 (c) – amount of time it takes THC:CBD to start working: “How satisfied or dissatisfied are you with the amount of time it takes the medication to start working?”; Question 4 (d) – usability of THC:CBD: “How easy or difficult is it to use the medication in its current form?”; Question 5 (e) – planning when to use THC:CBD: “How easy or difficult is it to plan when you will use the medication each time?”; Question 6 (f) – administration of THC:CBD as instructed: “How convenient or inconvenient is it to take the medication as instructed?”; Question 7 (g) – taking THC:CBD is a good thing: “Overall, how confident are you that taking this medication is a good thing for you?”; Question 8 (h) – the good things about THC:CBD outweigh the bad things: “How satisfied are you that the good things about this medication outweigh the bad things?”; Question 9 (i) – overall satisfaction THC:CBD: “Taking all things into account, how satisfied or dissatisfied are you with this medication”; n = number of patients

Back to article page